| Patient First New Jersey Physicians Group Llc | |
|
5000 Cox Rd Glen Allen VA 23060-9263 | |
| (807) 968-5700 | |
| Not Available |
| Full Name | Patient First New Jersey Physicians Group Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 5000 Cox Rd, Glen Allen, Virginia |
| Authorized Official Name and Position | Edward S. Sowers (VICE PRESIDENT) |
| Authorized Official Contact | 8049685700 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Patient First New Jersey Physicians Group Llc 5000 Cox Rd Glen Allen VA 23060-9263 Ph: (048) 224-3558 | Patient First New Jersey Physicians Group Llc 5000 Cox Rd Glen Allen VA 23060-9263 Ph: (807) 968-5700 |
| NPI Number | 1285317750 |
|---|---|
| Provider Enumeration Date | 08/10/2023 |
| Last Update Date | 01/03/2024 |
| Medicare PECOS PAC ID | 6608220322 |
|---|---|
| Medicare Enrollment ID | O20230929000762 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285317750 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QU0200X | Clinic/center - Urgent Care | (* (Not Available)) | Primary |
| Provider Name | Annabelle B Dimapilis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245229913 PECOS PAC ID: 4880680453 Enrollment ID: I20040421000615 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Marion L Patterson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194878991 PECOS PAC ID: 5799775649 Enrollment ID: I20040513001071 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Eileen M Singer |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1538191432 PECOS PAC ID: 7719959717 Enrollment ID: I20040810001152 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Randy M Zeid |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1073549655 PECOS PAC ID: 5092763359 Enrollment ID: I20050104000658 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Martin J Kessler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164446472 PECOS PAC ID: 9537191648 Enrollment ID: I20050914000411 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Nadine C Rosenthal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639159742 PECOS PAC ID: 2365467610 Enrollment ID: I20051006000249 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Nicholas J Talotta |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1104999390 PECOS PAC ID: 7315047057 Enrollment ID: I20070711000311 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Heidi L Handler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1578737987 PECOS PAC ID: 5890866834 Enrollment ID: I20080618000290 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Laura A Rutkiewicz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164498093 PECOS PAC ID: 4880718576 Enrollment ID: I20100902000037 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Nancy Bierman-dear |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689698813 PECOS PAC ID: 6406032226 Enrollment ID: I20110512000273 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Teresa Louise Conner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629481528 PECOS PAC ID: 5395963243 Enrollment ID: I20140905001945 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Temilola A Sopeju |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1033406673 PECOS PAC ID: 3971723578 Enrollment ID: I20141002001401 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Robert Sehgel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619230307 PECOS PAC ID: 2264746866 Enrollment ID: I20150727001175 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Isaac S Yoon |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417913310 PECOS PAC ID: 5799679080 Enrollment ID: I20150805007321 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Simon S Boulattouf |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821383761 PECOS PAC ID: 4486825411 Enrollment ID: I20151130001957 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Michael J Hicks |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1245232198 PECOS PAC ID: 7214072784 Enrollment ID: I20160222001995 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Faranak E Moghadam |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770548893 PECOS PAC ID: 6507750809 Enrollment ID: I20160302001979 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Roberta L Scherr |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1992887475 PECOS PAC ID: 4082614631 Enrollment ID: I20160823002710 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Aarti Aggarwal |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104192988 PECOS PAC ID: 2062654213 Enrollment ID: I20160830002925 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Nilofer J Tohfafarosh |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053672865 PECOS PAC ID: 3375868474 Enrollment ID: I20170308002717 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Grace H Lee |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245494210 PECOS PAC ID: 3476825258 Enrollment ID: I20170815002177 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Johnathan Val C Fagel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1639507510 PECOS PAC ID: 4880903681 Enrollment ID: I20180122003035 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Jasen R Sood |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053725960 PECOS PAC ID: 4587926308 Enrollment ID: I20180314002461 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Danish S Shahmehdi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407354939 PECOS PAC ID: 2769745611 Enrollment ID: I20180406001168 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Taher H Vajihuddin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508961426 PECOS PAC ID: 7911927728 Enrollment ID: I20180522000283 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Paul Wu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922084524 PECOS PAC ID: 9830140151 Enrollment ID: I20181003001132 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Malik A Massac |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831528017 PECOS PAC ID: 7810249174 Enrollment ID: I20181015001945 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Muhammad Imran |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740548718 PECOS PAC ID: 2264755636 Enrollment ID: I20181127001771 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Suzanne Rannazzisi |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1821482308 PECOS PAC ID: 4688993488 Enrollment ID: I20181217001278 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Britanne Doss |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1548688765 PECOS PAC ID: 0749571073 Enrollment ID: I20191010000193 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Dani Boulattouf |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1609006618 PECOS PAC ID: 5698812923 Enrollment ID: I20191105000175 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Michael Johnson |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1144365974 PECOS PAC ID: 9436256914 Enrollment ID: I20191108000835 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | John Goreczny |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235390956 PECOS PAC ID: 9234302043 Enrollment ID: I20210304000218 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | James Lacey |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184627747 PECOS PAC ID: 8820085178 Enrollment ID: I20210408001154 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Vincent Marchese |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790215853 PECOS PAC ID: 1557770443 Enrollment ID: I20210505001303 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Emmanuel Jean-louis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1962455014 PECOS PAC ID: 9537140082 Enrollment ID: I20221217000071 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Kevin Clarke Walpole |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558854414 PECOS PAC ID: 0042615486 Enrollment ID: I20230307002538 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Ayesha Bakhtiar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1912535592 PECOS PAC ID: 4183071038 Enrollment ID: I20231114002426 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
| Provider Name | Cible M. Parayil |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1750598264 PECOS PAC ID: 7911052824 Enrollment ID: I20240314000405 |
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
News Archive
Researchers from the University of Missouri School of Medicine have found that a new protocol that uses preventive blood-thinning medication in the treatment of patients with traumatic brain injuries reduces the risk of patients developing life-threatening blood clots without increasing the risk of bleeding inside the brain.
HealthCare.gov is working better, so the technical barriers to pushing people into new plans aren't as high. The law, meanwhile, attempts to establish a norm that all Americans should have coverage of a certain quality and comprehensiveness. In general and over time, this is good for them and for the system as a whole.
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers - an essential step on the path to developing drugs to target these proteins.
Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.
› Verified 4 days ago
Patient First Richmond Physician's Group Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5000 Cox Rd, Suite 100, Glen Allen, VA 23060 Phone: 804-968-5700 Fax: 804-217-7991 | |
Concentra Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9900 W Broad St, Suite C, Glen Allen, VA 23060 Phone: 804-358-0361 | |
Allyalign Health, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10900 Nuckols Rd, Suite 110, Glen Allen, VA 23060 Phone: 804-747-0720 Fax: 804-823-2568 | |
Glen Allen Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5207 Hickory Park Dr, Suite A, Glen Allen, VA 23059 Phone: 804-612-2980 Fax: 804-762-7102 | |
Glen Allen Medi Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11551 Nuckols Rd Ste C, Glen Allen, VA 23059 Phone: 704-926-7546 | |
Innsbrook Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4900 Cox Rd, Suite 150, Glen Allen, VA 23060 Phone: 804-346-1780 Fax: 804-346-1781 | |
Dada Bhagwan Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5028 Hickory Meadows Pl, Glen Allen, VA 23059 Phone: 804-514-6958 Fax: 804-282-9135 |